Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
Jennifer G. Robinson(University of Iowa), Allan D. Sniderman(Université de Montréal), Jan Borén(Sahlgrenska University Hospital), Stephen J. Nicholls(Australian Centre for Heart Health), Pamela S. Douglas(Duke University), Michael Pencina(Tufts Medical Center), Venkatesh Mani(Icahn School of Medicine at Mount Sinai), Samuel S. Gidding, Ira Tabas(Columbia University), Børge G. Nordestgaard(Herlev Hospital), Edward A. Fisher(New York University), Neha J. Pagidipati(Alnylam Pharmaceuticals (United States)), Zahi A. Fayad(Icahn School of Medicine at Mount Sinai), K.-A. Rye(UNSW Sydney), Chris J. Packard(University of Glasgow), Anne Tybjærg‐Hansen(University of Copenhagen), Kevin Jon Williams(Temple University)
Cited by 105
Related Papers
General Cardiovascular Risk Profile for Use in Primary Care
|Circulation|2008|7.4k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
|Journal of the American College of Cardiology|2017|6.5k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k